NEW YORK CITY, NY / ACCESS Newswire / November 18, 2026 / NeuroPace, Inc. (NASDAQ: NPCE) shares fell after the Company reported third-quarter 2026 revenue of $23.1 million, roughly 15% below consensus of approximately $27.1 million. It also cut full-year 2026 revenue guidance to $91 million to $92 million, down from $99.5 million to $101.5 million. If you bought NPCE stock and are now holding a loss, you are encouraged to submit your NeuroPace loss information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Management tied the shortfall to three pressure points. The first was a restructuring of the Company's sales force. The second was disruptions at several large customer accounts. The third was the continuing effect of exiting the SEEG distribution business. Total quarterly revenue declined 1.1% year over year, and NeuroPace posted a net loss of $3.3 million, or $(0.10) per share.
The revised outlook removes roughly $9 million from the midpoint of prior full-year guidance, a reduction of approximately 9%. Levi & Korsinsky is investigating whether NeuroPace may not have adequately disclosed the risks tied to its sales organization and its exposure to large customer accounts. The investigation is also examining whether affected investors may have claims for potential securities law violations.
Shareholders who lost money on NeuroPace following the guidance cut can request a free review of their NPCE losses or call (212) 363-7500.
ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.
Frequently Asked Questions About the NPCE Investigation
Q: What is the NPCE investigation about? A: A securities investigation is pending concerning NeuroPace (NASDAQ: NPCE) regarding potentially materially false or misleading statements. Shares fell after the Company disclosed third-quarter 2026 revenue of $23.1 million, roughly 15% below consensus. The Company also cut its full-year 2026 revenue guidance to $91 million to $92 million, causing losses for shareholders.
Q: Who is eligible to participate in the NPCE investigation? A: Investors who purchased NPCE stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do NPCE investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my NPCE shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought NPCE and sold at a loss may still participate in the investigation.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
